Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1987 1
1989 1
1990 2
1992 1
1993 1
1994 1
1995 2
1996 1
1997 3
2000 1
2001 1
2002 2
2003 5
2004 8
2005 6
2006 4
2007 6
2008 3
2009 7
2010 6
2011 10
2012 5
2013 2
2014 3
2015 4
2016 3
2017 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Results by year
Filters applied: . Clear all
Page 1
EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells.
Dillard C, Kiyohara M, Mah V, McDermott SP, Bazzoun D, Tsui J, Chan AM, Haddad G, Pellegrini M, Chang YL, Elshimali Y, Wu Y, Vadgama JV, Kim SR, Goodglick L, Law SM, Patel DD, Dhawan P, O'Brien NA, Gordon LK, Braun J, Lazar G, Wicha MS, Wadehra M. Dillard C, et al. Among authors: goodglick l. Mol Cancer Ther. 2020 Aug;19(8):1682-1695. doi: 10.1158/1535-7163.MCT-19-0850. Epub 2020 May 25. Mol Cancer Ther. 2020. PMID: 32451329 Free PMC article.
HIV-1 gp120: a novel viral B cell superantigen.
Townsley-Fuchs J, Neshat MS, Margolin DH, Braun J, Goodglick L. Townsley-Fuchs J, et al. Among authors: goodglick l. Int Rev Immunol. 1997;14(4):325-38. doi: 10.3109/08830189709116523. Int Rev Immunol. 1997. PMID: 9186784 Review.
SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.
Sun QY, Ding LW, Xiao JF, Chien W, Lim SL, Hattori N, Goodglick L, Chia D, Mah V, Alavi M, Kim SR, Doan NB, Said JW, Loh XY, Xu L, Liu LZ, Yang H, Hayano T, Shi S, Xie D, Lin DC, Koeffler HP. Sun QY, et al. Among authors: goodglick l. J Pathol. 2015 Mar;235(4):559-70. doi: 10.1002/path.4482. Epub 2014 Dec 18. J Pathol. 2015. PMID: 25404354 Free PMC article.
EMP2 is a novel therapeutic target for endometrial cancer stem cells.
Kiyohara MH, Dillard C, Tsui J, Kim SR, Lu J, Sachdev D, Goodglick L, Tong M, Torous VF, Aryasomayajula C, Wang W, Najafzadeh P, Gordon LK, Braun J, McDermott S, Wicha MS, Wadehra M. Kiyohara MH, et al. Among authors: goodglick l. Oncogene. 2017 Oct 19;36(42):5793-5807. doi: 10.1038/onc.2017.142. Epub 2017 Jun 12. Oncogene. 2017. PMID: 28604744 Free PMC article.
Pentraxin-3 is a novel biomarker of lung carcinoma.
Diamandis EP, Goodglick L, Planque C, Thornquist MD. Diamandis EP, et al. Among authors: goodglick l. Clin Cancer Res. 2011 Apr 15;17(8):2395-9. doi: 10.1158/1078-0432.CCR-10-3024. Epub 2011 Jan 21. Clin Cancer Res. 2011. PMID: 21257721
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.
Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, Goodman GE, Thornquist MD, Liu G, de Perrot M, Tsao MS, Goparaju C. Pass HI, et al. Among authors: goodglick l. N Engl J Med. 2012 Oct 11;367(15):1417-27. doi: 10.1056/NEJMoa1115050. N Engl J Med. 2012. PMID: 23050525 Free PMC article.
Lung cancer chemoprevention with celecoxib in former smokers.
Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. Mao JT, et al. Among authors: goodglick l. Cancer Prev Res (Phila). 2011 Jul;4(7):984-93. doi: 10.1158/1940-6207.CAPR-11-0078. Cancer Prev Res (Phila). 2011. PMID: 21733822 Free PMC article. Clinical Trial.
89 results